Aspirin and Extended – Release Dipyridamole Capsules, 25 mg / 200 mg (Par Pharmaceutical, Inc.)
Welcome to the PulseAid listing for the Aspirin and Extended – Release Dipyridamole Capsules, 25 mg / 200 mg drug offered from Par Pharmaceutical, Inc.. This Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Par Pharmaceutical, Inc. |
NON-PROPRIETARY NAME: | Aspirin and Extended – Release Dipyridamole |
SUBSTANCE NAME: | ASPIRIN; DIPYRIDAMOLE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-01-30 |
END MARKETING DATE: | 0000-00-00 |
Aspirin and Extended – Release Dipyridamole Capsules, 25 mg / 200 mg HUMAN PRESCRIPTION DRUG Details:
Item Description | Aspirin and Extended – Release Dipyridamole Capsules, 25 mg / 200 mg from Par Pharmaceutical, Inc. |
LABELER NAME: | Par Pharmaceutical, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 25; 200(mg/1; mg/1) |
START MARKETING DATE: | 2017-01-30 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 49884-007_bfa0e7a7-973f-4a42-ab00-2c2a2382020e |
PRODUCT NDC: | 49884-007 |
APPLICATION NUMBER: | ANDA207944 |
Other ASPIRIN; DIPYRIDAMOLE Pharmaceutical Manufacturers / Labelers: